B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

USP28

MOLECULAR TARGET

ubiquitin specific peptidase 28

UniProt: Q96RU2NCBI Gene: 5764610 compounds

USP28 (ubiquitin specific peptidase 28) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting USP28

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1carnosol1.102
2prunetin1.102
3Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
4Quercetin0.691
5alpha-Linolenic Acid0.691
6salvin [Supplementary Concept]0.691
7celastrol0.691
8piceatannol0.691
9pyrrolnitrin0.691
10withaferin0.691

About USP28 as a Drug Target

USP28 (ubiquitin specific peptidase 28) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented USP28 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

USP28 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.